Health Care/Hospital
Second Global Health Forum of Boao Forum for Asia Deepens Understanding of Universal Health and Global Cooperation
QINGDAO, China, June 4, 2021 /PRNewswire/ -- The Boao Forum for Asia (BFA) hosts the second Global Health Forum (The Forum) inQingdao. With rising consensus in the health field in the context of the pandemic, the Forum, with the aim of achieving the shared vision of "Health for All", saw partners...
2021-06-04 20:03
3088
WhaleTeq Launches First AED Management Platform with DFS200 to Provide Most Effective and Efficient Maintenance Solution
TAIPEI, June 4, 2021 /PRNewswire/ -- WhaleTeq, a Taiwan-based Innovative medical device testing solution company, launches the first AED management platform with their latest defibrillator tester, DFS200, to fill in the AED testing and maintenance gap. AED testing and maintenance is of great impo...
2021-06-04 19:38
3689
VeChain, Together With DNV, Enables Renji Hospital To Launch The World's First Blockchain-based IVF Service App - MyBaby
SHANGHAI, June 4, 2021 /PRNewswire/ -- In partnership with VeChain and DNV, Renji Hospital, a top-ranking hospital inChina affiliated with the Shanghai Jiaotong University School of Medicine has announced the launch of smart medical care project - MyBaby, the world's first blockchain-based In-Vit...
2021-06-04 18:39
6099
Oxygen Concentrators have arrived, 135 oxygen concentrators donated by Fosun and its friendly enterprises arrive in Mumbai
HONG KONG, June 4, 2021 /PRNewswire/ -- On 1 June 2021, 135 oxygen concentrators, 5 ventilators, and 3,300 KN95 masks donated by Fosun Foundation ( Shanghai) (hereinafter referred to as "Fosun Foundation") and its friendly enterprises arrived inMumbai. This is the largest batch of oxygen concentra...
2021-06-04 16:48
2141
Sihuan Pharmaceutical (0460.HK) Obtained the Exclusive Distribution Right for LipiVage(R) Fat Collection System in Greater China and South Korea
HONG KONG, June 4, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; Hong Kong Stock Exchange stock code: 0460) is pleased to announce that Meiyen Laboratory Inc, an Am...
2021-06-04 14:03
8928
DiNovA's Israel Incubator officially opens its office in Caesarea
CAESAREA, Israel, June 4, 2021 /PRNewswire/ -- China headquartered DiNovA Medtech officially takes up residence in Caesarea Industry and Business Park for itsIsrael incubator, which continues to help augment the company's global footprint. DiNovA Medtech is not new to Israel. Its leadership team...
2021-06-04 14:00
1637
Elekta Nomination Committee's proposed Board of Directors for the 2021 Annual General Meeting
STOCKHOLM, June 4, 2021 /PRNewswire/ -- The Nomination Committee of Elekta (EKTA-B.ST) proposes that the 2021 Annual General Meeting re-elect Board members Laurent Leksell, who is also proposed to be re-elected as Chairman of the Board, Caroline Leksell Cooke, Johan Malmquist, Wolfgang Reim, Jan Se...
2021-06-04 13:56
1821
Prixa Closes US$3 million in Additional Funding to Enhance Accessibility and Digital Transformation of Indonesian Healthcare Services
* Funding led by MDI Ventures (MDI) and the Trans-Pacific Technology Fund (TPTF) with participation from existing investors including Siloam Hospitals Group. * This strategic investment will allow Prixa to expand its digital healthcare platform and user base. * Prixa is a leading health-tec...
2021-06-04 11:13
2356
Antengene Announces Publication of Abstract on XPO1 Inhibitor Selinexor in Relapsed or Refractory Multiple Myeloma at ASCO 2021 and EHA 2021
SHANGHAI and HONG KONG, June 4, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-06-04 08:00
2761
Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy
SINGAPORE, June 4, 2021 /PRNewswire/ -- Vela Diagnostics announced a collaboration with the National Cancer Centre ofSingapore (NCCS) to develop a molecular diagnostic assay to predict individual patients' responses to a cancer therapy called Epidermal Growth Factor Receptor (EGFR) tyrosine kinas...
2021-06-04 08:00
1785
WCPGHAN 2021: Fish oil taken during pregnancy boosts problem-solving and concentration in children, new data reveals
GENEVA, June 4, 2021 /PRNewswire/ -- Children born to mothers who took fish oil in their pregnancies have been shown to have faster problem-solving skills and better attention focus at age 10, according to findings from an EU funded study presented today at the 6th World Congress of Paediatric Ga...
2021-06-04 07:01
2132
The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial
1. VISEN Pharmaceuticals has obtained the investigational new drug (IND) approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for the phase III China clinical trial (PaTHway China Trial) of TransCon PTH Solution for Injection (TransCon™ parathy...
2021-06-04 02:00
1904
RWDC Industries Appoints New Chief Financial Officer
Thomas Aebischer brings 18 years of public and private company CFO experience and proven leadership track record to RWDC ATHENS, Georgia and SINGAPORE, June 3, 2021 /PRNewswire/ -- RWDC Industries, a biotechnology company on a mission to replace single-use plastics through innovative and cost-ef...
2021-06-03 22:00
2063
Innovent and Lilly Jointly Announce the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with Gemcitabine and Platinum Chemotherapy as First-Line Therapy for People with Squamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, June 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...
2021-06-03 17:09
4391
Peking University Biologics entering into Strategic Cooperation Agreement with Norwich Investment Limited
HONG KONG, June 3, 2021 /PRNewswire/ -- Peking University Biologics (hereinafter known as "PKU BIO") and Norwich Investment Limited (hereinafter known as "Norwich") announced today that both parties have entered into a Strategic Cooperation Agreement ("Agreement") to promote the business develop...
2021-06-03 16:29
2646
Innophys Releases "MUSCLE SUIT Every" in Italy
TOKYO, June 3, 2021 /PRNewswire/ -- - Accelerating Sales in EU Member Countries - Innophys Co., Ltd. (hereinafter "Innophys") released wearable work-assisting robotic suit "MUSCLE SUIT Every" inItaly on June 3 as part of its efforts to promote the sale of the product overseas, particularly in th...
2021-06-03 14:00
1280
Grifols to provide Korean Red Cross with Procleix Panther for blood screening, extending donor testing leadership in Asia
- The 28 systems to be deployed across KRC's three laboratory sites will test about 94% of the country's blood donations - They will run the Procleix Ultrio Elite Assay, an advanced nucleic acid test (NAT) ensuring donation safety by detecting the potential presence of the most important infecti...
2021-06-03 11:00
2701
Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology's Medical Journal "Blood"
SAN FRANCISCO, U.S. and SUZHOU, China, June 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major ...
2021-06-03 08:00
4417
First Patient Dosed in QBiotics & MSD Clinical Trial Collaboration for Unresectable Melanoma
* First patient dosed with QBiotics' lead oncology molecule tigilanol tiglate in combination with KEYTRUDA® (pembrolizumab) in a clinical trial collaboration with MSD (tradename of Merck & Co., Inc.,Kenilworth, NJ, USA) * The Phase Ib/IIa study will test the safety, optimal dose and tumour re...
2021-06-03 06:00
1823
IDEXX Acquires ezyVet
Global leader in veterinary diagnostics and software enhances its practice management portfolio with acquisition of leading cloud-based solution WESTBROOK, Maine, June 3, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, announc...
2021-06-03 04:53
12605
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7877
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6970
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4263
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2911